Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

BACKGROUND: Cumulative evidence from epidemiological, preclinical and clinical studies suggests estrogens may have psychoprotective effects in schizophrenic patients. Selective Estrogen Receptor Modulators could have therapeutic benefits in schizophrenia for both sexes without being hazardous to gyn...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kianimehr, Gilda, Fatehi, Farzad, Hashempoor, Sara, Khodaei-Ardakani, Mohammad-Reza, Rezaei, Farzin, Nazari, Ali, Kashani, Ladan, Akhondzadeh, Shahin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100751/
https://ncbi.nlm.nih.gov/pubmed/25012765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-55
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller